血小板衍生生长因子-D使肝脏肌成纤维细胞促进胆管癌肿瘤淋巴管生成
该研究探讨PDGF-D与肝脏肌成纤维细胞在胆管癌淋巴管生成中的作用。结果显示,PDGF-D刺激成纤维细胞分泌VEGF-C和VEGF-A,促进淋巴内皮细胞募集、三维组装及肿瘤细胞跨内皮迁移,上述效应可被伊马替尼抑制;在大鼠模型中,navitoclax诱导的CAF耗竭显著减少淋巴管化和淋巴结转移。结论认为诱导CAF凋亡或抑制PDGF-D诱导轴可能阻断胆管癌早期转移。
要点
- 胆管癌中CAF与LEC紧密相邻,CAF表达VEGF-A和VEGF-C,LEC表达VEGFR2和VEGFR3。
- PDGF-D刺激成纤维细胞分泌VEGF-C和VEGF-A增加,促进LEC募集、三维组装、单层通透性及EGI-1跨内皮迁移。
- 上述效应均被PDGFRβ抑制剂伊马替尼抑制;大鼠模型中navitoclax诱导CAF耗竭显著减少淋巴管化和淋巴结转移。
核心结论
- PDGF-D刺激成纤维细胞产生VEGF-C和VEGF-A,导致淋巴脉管系统扩张和肿瘤细胞血管内渗入。
- 该胆管癌早期转移的关键过程可能通过诱导CAF凋亡或抑制PDGF-D诱导轴被阻断。
研究设计与样本
- 对人胆管癌标本进行podoplanin、α-SMA、VEGF-A、VEGF-C及其受体VEGFR2、VEGFR3免疫染色。
- 评估来自原发性硬化性胆管炎外植体的人成纤维细胞中VEGF-A和VEGF-C的分泌。
- 将人LEC与PDGF-D刺激的成纤维细胞条件培养基孵育,评估迁移、三维血管组装、跨内皮电阻及EGI-1胆管癌细胞跨内皮迁移。
- 在大鼠胆管癌模型中研究BH3模拟物navitoclax选择性耗竭CAF对LEC密度和淋巴结转移的影响。
主要发现
- 胆管癌标本中CAF与LEC紧密相邻,CAF表达VEGF-A和VEGF-C,LEC表达VEGFR2和VEGFR3。
- PDGF-D刺激后成纤维细胞分泌VEGF-C和VEGF-A增加。
- PDGF-D刺激的成纤维细胞诱导LEC募集和三维组装,增加LEC单层通透性,并促进EGI-1跨内皮迁移。
- 上述效应均被PDGFRβ抑制剂伊马替尼抑制。
- 大鼠胆管癌模型中,navitoclax诱导的CAF耗竭显著减少淋巴管化和淋巴结转移。
临床怎么用
- 作者认为,靶向成纤维细胞或PDGF-D诱导的信号可能代表阻断肿瘤相关淋巴管生成并减少胆管癌侵袭性的有效工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: In cholangiocarcinoma, early metastatic spread via lymphatic vessels often precludes curative therapies. Cholangiocarcinoma invasiveness is fostered by an extensive stromal reaction, enriched in cancer-associated fibroblasts (CAFs) and lymphatic endothelial cells (LECs). Cholangiocarcinoma cells recruit and activate CAFs by secreting PDGF-D. Herein, we investigated the role of PDGF-D and liver myofibroblasts in promoting lymphangiogenesis in cholangiocarcinoma. METHODS: Human cholangiocarcinoma specimens were immunostained for podoplanin (LEC marker), α-SMA (CAF marker), VEGF-A, VEGF-C, and their cognate receptors (VEGFR2, VEGFR3). VEGF-A and VEGF-C secretion was evaluated in human fibroblasts obtained from primary sclerosing cholangitis explants. Using human LECs incubated with conditioned medium from PDGF-D-stimulated fibroblasts we assessed migration, 3D vascular assembly, transendothelial electric resistance and transendothelial migration of cholangiocarcinoma cells (EGI-1). We then studied the effects of selective CAF depletion induced by the BH3 mimetic navitoclax on LEC density and lymph node metastases in vivo. RESULTS: In cholangiocarcinoma specimens, CAFs and LECs were closely adjacent. CAFs expressed VEGF-A and VEGF-C, while LECs expressed VEGFR2 and VEGFR3. Upon PDGF-D stimulation, fibroblasts secreted increased levels of VEGF-C and VEGF-A. Fibroblasts, stimulated by PDGF-D induced LEC recruitment and 3D assembly, increased LEC monolayer permeability, and promoted transendothelial EGI-1 migration. These effects were all suppressed by the PDGFRβ inhibitor, imatinib. In the rat model of cholangiocarcinoma, navitoclax-induced CAF depletion, markedly reduced lymphatic vascularization and reduced lymph node metastases. CONCLUSION: PDGF-D stimulates VEGF-C and VEGF-A production by fibroblasts, resulting in expansion of the lymphatic vasculature and tumor cell intravasation. This critical process in the early metastasis of cholangiocarcinoma may be blocked by inducing CAF apoptosis or by inhibiting the PDGF-D-induced axis. LAY SUMMARY: Cholangiocarcinoma is a highly malignant cancer affecting the biliary tree, which is characterized by a rich stromal reaction involving a dense population of cancer-associated fibroblasts that promote early metastatic spread. Herein, we show that cholangiocarcinoma-derived PDGF-D stimulates fibroblasts to secrete vascular growth factors. Thus, targeting fibroblasts or PDGF-D-induced signals may represent an effective tool to block tumor-associated lymphangiogenesis and reduce the invasiveness of cholangiocarcinoma.
引用
- Cadamuro M, Brivio S, Mertens J, et al. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. J Hepatol. 2018. PMID: 30553841. doi:10.1016/j.jhep.2018.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。